SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaissance Pharmaceuticals (GNSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bread Upon The Water who wrote (113)10/6/2002 8:41:35 PM
From: Mike McFarland  Read Replies (2) of 183
 
...Genaissance approach, which we call HAP™ Technology, combines our proprietary haplotype markers, known as HAP™ Markers, with a sophisticated software tool, our DecoGen® informatics system and HAP™ Typing Services, for measuring which of our HAP™ Markers are present in a patient's clinical blood sample.

Looks good on paper, how come I'm not HAP HAP HAPPY!
Still own any?

I bought some for a little over a buck this
past summer--don't think I will average down.
Thoughts?

Maybe some intern will trip over an undiscovered
market, they'll patent it, and I'll get rich! Sigh.
Could have had one of the better rooms at the
Bellagio (for a week or two) for what I've lost
on this, dammit!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News